1. Home
  2. MXCT vs CIO Comparison

MXCT vs CIO Comparison

Compare MXCT & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • CIO
  • Stock Information
  • Founded
  • MXCT 1999
  • CIO 2013
  • Country
  • MXCT United States
  • CIO Canada
  • Employees
  • MXCT N/A
  • CIO N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CIO Real Estate Investment Trusts
  • Sector
  • MXCT Health Care
  • CIO Real Estate
  • Exchange
  • MXCT Nasdaq
  • CIO Nasdaq
  • Market Cap
  • MXCT 242.4M
  • CIO 221.6M
  • IPO Year
  • MXCT 2021
  • CIO 2014
  • Fundamental
  • Price
  • MXCT $2.04
  • CIO $6.95
  • Analyst Decision
  • MXCT Strong Buy
  • CIO Hold
  • Analyst Count
  • MXCT 2
  • CIO 1
  • Target Price
  • MXCT $7.50
  • CIO N/A
  • AVG Volume (30 Days)
  • MXCT 473.0K
  • CIO 1.0M
  • Earning Date
  • MXCT 08-06-2025
  • CIO 07-31-2025
  • Dividend Yield
  • MXCT N/A
  • CIO 5.77%
  • EPS Growth
  • MXCT N/A
  • CIO N/A
  • EPS
  • MXCT N/A
  • CIO N/A
  • Revenue
  • MXCT $37,675,000.00
  • CIO $168,892,000.00
  • Revenue This Year
  • MXCT $8.36
  • CIO $1.13
  • Revenue Next Year
  • MXCT $20.14
  • CIO $3.73
  • P/E Ratio
  • MXCT N/A
  • CIO N/A
  • Revenue Growth
  • MXCT N/A
  • CIO N/A
  • 52 Week Low
  • MXCT $1.97
  • CIO $4.19
  • 52 Week High
  • MXCT $5.20
  • CIO $6.96
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 40.39
  • CIO 80.44
  • Support Level
  • MXCT $2.18
  • CIO $6.91
  • Resistance Level
  • MXCT $2.31
  • CIO $6.96
  • Average True Range (ATR)
  • MXCT 0.11
  • CIO 0.09
  • MACD
  • MXCT -0.01
  • CIO 0.11
  • Stochastic Oscillator
  • MXCT 18.52
  • CIO 99.69

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About CIO City Office REIT Inc.

City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.

Share on Social Networks: